UK clinical trial set-up times drop significantly
Efforts by the National Institute for Health and Care Research (NIHR) have led to a fall in clinical research study set-up times, new UK government figures have revealed.
Data show that the time taken to set up commercial interventional clinical trials in the UK has fallen significantly, with the average (median) set-up time for commercial trials dropping to 100 days in the final quarter of 2025/26, down from 153 days over the same period in 2024/25.
Monthly KPI data shows an upward trajectory rising from 73% of commercial interventional clinical trials setting up on target in the first quarter of 2025/26 to 100% in the final quarter.
Professor Lucy Chappell, NIHR Chief Executive Officer and DHSC Chief Scientific Adviser, said: “Faster study set-up means patients can gain access to promising new treatments sooner, giving more people the opportunity to benefit from the latest advances in areas such as cancer, vaccines and rare diseases.
“Through our Industry Hub, a one-stop shop for sponsors looking to run research in the UK, and our UK-wide network of Commercial Research Delivery Centres, NIHR is making it much easier to bring world-leading trials to the UK.”
Commercial partners are also benefitting from a coordinated pathway through the NIHR’s Industry Hub, Commercial Research Delivery Centres and national infrastructure.
Other NIHR initiatives include Be Part of Research – a digital platform connecting volunteers with active trials.
Examples include:
- BEATRIX study: Testing a new vaccine given during pregnancy to protect newborns from group B streptococcus (GBS) infections.
- World-first lupus trial: Delivering CAR-T cell therapy to patients fighting severe autoimmune disease.
- CHILL study: An early-phase trial where NIHR support enabled the UK to screen its first participant just 113 days after entering set-up.
- Nova 301 study: A norovirus vaccine trial by Moderna that recruited 2,500 volunteers in nine weeks using NIHR tools.
